mhurhangee/ep-ind-claims huggingface dataset:
An illumination device for a motor vehicle, comprising a light source formed of a number of semiconductor diodes, and also a scanning means onto which light from the light source falls and which during operation of the illumination device produces a deflection of the incident light from the light source which varies over time and thereby a specified light distribution at a distance from the illumination device, wherein the scanning means comprises at least two separately actuatable scanners (3, 3') onto which in each case a separate light beam (L, L') produced from the light of the light source falls, the deflection of which beam is varied over time by the respective scanner (3, 3'), characterised in that a stop is arranged in the optical path of the light beams (L, L') after deflection by the scanning means, the stop bringing about a subdivision of an image plane into two regions, with in at least one operating mode of the illumination device one part of the scanners of the scanning means being provided exclusively for deflection of light beams in a region on one side of the stop, and the other part of the scanners of the scanning means being provided exclusively for deflection of light beams (L') in a region on the other side of the stop.
An internal gear pump comprising: a rotor/torque ring comprising: an internally lobed rotor an externally lobed element encircled by the rotor; a hollow shaft supporting the externally lobed element; a pressure relief element positioned to shift between a first condition and a second condition; and a spring biasing the pressure relief element toward the first condition from the second condition, characterized in that the externally lobed element is an idler; and in that the internal gear pump further comprises a torque ring extending beyond at least a first end of the rotor; and in that the torque ring has at least one pressure relief port (240A, 240B) positioned so that: in the first condition, the pressure relief element blocks a path from an interior volume of the pump between the external lobes of the idler and the internal lobes of the rotor to the at least one pressure relief port (240A, 240B); and in the second condition, relative to the first condition the pressure relief element does not block the path. a rotor/torque ring comprising: an internally lobed rotor an internally lobed rotor an externally lobed element encircled by the rotor; a hollow shaft supporting the externally lobed element; a pressure relief element positioned to shift between a first condition and a second condition; and a spring biasing the pressure relief element toward the first condition from the second condition, characterized in that the externally lobed element is an idler; and in that the internal gear pump further comprises a torque ring extending beyond at least a first end of the rotor; and in that the torque ring has at least one pressure relief port (240A, 240B) positioned so that: in the first condition, the pressure relief element blocks a path from an interior volume of the pump between the external lobes of the idler and the internal lobes of the rotor to the at least one pressure relief port (240A, 240B); and in the second condition, relative to the first condition the pressure relief element does not block the path. in the first condition, the pressure relief element blocks a path from an interior volume of the pump between the external lobes of the idler and the internal lobes of the rotor to the at least one pressure relief port (240A, 240B); and in the second condition, relative to the first condition the pressure relief element does not block the path.
An electrical high-voltage switching device having a rod which is displaceable approximately in the longitudinal direction and has a circumferential groove in which a sliding ring is provided, characterized in that said sliding ring consists of a strip material having two ends (21, 22) which engage with each other and form a positive connection.
A method for the generation of a binding protein derived from di-ubiquitin having the amino acid sequence of SEQ ID NO: 4, wherein said binding protein binds to a given target selected from a peptide, a protein or a domain of a protein with a dissociation constant of at least 1000 nM, said method comprising: a) subjecting nucleotide triplets of a nucleic acid molecule of di-ubiquitin (SEQ ID NO: 4) to mutagenesis in 12, 13, or 14 positions coding for amino acid positions R42, 144, H68, V70, R72, L73, R74, K82, L84, Q138, K139, E140, S141, and T142 of the linear polypeptide sequence of di-ubiquitin (SEQ ID NO: 4), resulting in one or more mutein nucleic acid molecule(s), b) expressing the one or more mutein nucleic acid molecule(s) obtained in (a) in a suitable expression system, c) enriching the one or more di-ubiquitin mutein(s) having a dissociation constant of at least 1000 nM for the given target by means of selection and/or isolation, and wherein said binding protein has between 85 % and 92 % sequence identity to di-ubiquitin (SEQ ID NO: 4), and wherein the affinity to the target is at least 10fold higher than for di-ubiquitin (SEQ ID NO: 4). a) subjecting nucleotide triplets of a nucleic acid molecule of di-ubiquitin (SEQ ID NO: 4) to mutagenesis in 12, 13, or 14 positions coding for amino acid positions R42, 144, H68, V70, R72, L73, R74, K82, L84, Q138, K139, E140, S141, and T142 of the linear polypeptide sequence of di-ubiquitin (SEQ ID NO: 4), resulting in one or more mutein nucleic acid molecule(s), b) expressing the one or more mutein nucleic acid molecule(s) obtained in (a) in a suitable expression system, c) enriching the one or more di-ubiquitin mutein(s) having a dissociation constant of at least 1000 nM for the given target by means of selection and/or isolation, and wherein said binding protein has between 85 % and 92 % sequence identity to di-ubiquitin (SEQ ID NO: 4), and wherein the affinity to the target is at least 10fold higher than for di-ubiquitin (SEQ ID NO: 4). wherein said binding protein has between 85 % and 92 % sequence identity to di-ubiquitin (SEQ ID NO: 4), and wherein the affinity to the target is at least 10fold higher than for di-ubiquitin (SEQ ID NO: 4).
System for the treatment of blood, in particular for the safe removal of CO2 and Bicarbonates from the blood, in a blood circuit connectable to a patient by means of a venous-venous connection having at least an inlet or tube line for receiving a flow of blood for CO2 or bicarbonate removal and an outlet or tube line for the blood deprived of CO2 or bicarbonate, and a hemofilter or dialyzer, disposed between said inlet and said outlet, and provided with means for separating the plasmatic water from the blood and for conveying the same plasmatic water through a second tube line; characterized in that it comprises a device for removing bicarbonates and/or CO2, disposed and acting on said second tube line, in a position which is downstream of said hemofilter and upstream of a third tube line which brings back the treated plasmatic water in the blood circuit downstream of said hemofilter.
A method of electroporating a mammalian cell, the method comprising the steps of: flowing a suspension of mammalian cells in a conductive physiological buffer to be electroporated into a flow channel; exposing the suspension of mammalian cells in the flow channel to an electric field having a strength of 2.1 kV/cm that is applied in four pulses, each pulse having a duration of 0.4 ms, for a total duration of 1.6 ms; and flowing the suspension of mammalian cells out of the flow channel. flowing a suspension of mammalian cells in a conductive physiological buffer to be electroporated into a flow channel; exposing the suspension of mammalian cells in the flow channel to an electric field having a strength of 2.1 kV/cm that is applied in four pulses, each pulse having a duration of 0.4 ms, for a total duration of 1.6 ms; and flowing the suspension of mammalian cells out of the flow channel.
A breathing assistance apparatus that provides a flow of gases to a patient, the breathing assistance apparatus comprising: at least one gases flow path configured to direct the flow of gases to the patient; a gases flow inlet configured to receive the flow of gases from a gases flow source; a temperature sensor configured to measure a temperature of the flow of gases; wherein, the breathing assistance apparatus further comprises: a gases flow rate sensing system configured to measure a gases flow rate of the flow of gases, wherein the gases flow rate sensing system is configured to operate in at least two different target temperature modes based upon the measured temperature of the flow of gases, wherein the gases flow rate sensing system comprises a thermistor circuit and in each of the target temperature modes, the thermistor circuit is configured to operate at an associated target temperature, characterized in that the target temperature is maintained constant in a temperature mode, and wherein the gases flow rate sensing system is configured to change from a first temperature mode to a second temperature mode in response to the measured temperature of the flow of gases meeting a predetermined threshold. at least one gases flow path configured to direct the flow of gases to the patient; a gases flow inlet configured to receive the flow of gases from a gases flow source; a temperature sensor configured to measure a temperature of the flow of gases; wherein, the breathing assistance apparatus further comprises: a gases flow rate sensing system configured to measure a gases flow rate of the flow of gases, wherein the gases flow rate sensing system is configured to operate in at least two different target temperature modes based upon the measured temperature of the flow of gases, wherein the gases flow rate sensing system comprises a thermistor circuit and in each of the target temperature modes, the thermistor circuit is configured to operate at an associated target temperature, characterized in that the target temperature is maintained constant in a temperature mode, and wherein the gases flow rate sensing system is configured to change from a first temperature mode to a second temperature mode in response to the measured temperature of the flow of gases meeting a predetermined threshold. a gases flow rate sensing system configured to measure a gases flow rate of the flow of gases, wherein the gases flow rate sensing system is configured to operate in at least two different target temperature modes based upon the measured temperature of the flow of gases, wherein the gases flow rate sensing system comprises a thermistor circuit and in each of the target temperature modes, the thermistor circuit is configured to operate at an associated target temperature, characterized in that the target temperature is maintained constant in a temperature mode, and wherein the gases flow rate sensing system is configured to change from a first temperature mode to a second temperature mode in response to the measured temperature of the flow of gases meeting a predetermined threshold.
A computer implemented control method for filtering out a powerline frequency interference signal from a multi-channel ECG-signal, comprising: rectifying a raw multi-channel ECG signal in a preset segment; extracting sinusoidal parameters of powerline frequency interference, the parameters including frequency, amplitude, and phase; reconstructing a powerline frequency interference sinusoidal waveform according to the frequency, amplitude, and phase; subtracting the reconstructed powerline frequency interference sinusoidal waveform from the preset segment of the ECG signal to output a clean ECG waveform signal; characterized in that, the powerline frequency interference frequency extracted from a segment of ECG is determined by the following formula: f 0 = 1 ∑ n = 1 L a n SD n ⋅ ∑ n = 1 L a n SD n f n where L is the number of channels with the highest signal-to-noise ratio selected in the raw multi-channel ECG signal, a n is the amplitude of the powerline frequency interference signal of the nth channel estimated by a RAW-STEM method, SD n is the standard deviation of the nth channel, f n is the frequency estimate of the powerline frequency interference signal of the nth channel, and f o is the estimated frequency of the powerline frequency interference signal of all channels of the multi-channel ECG signal rectifying a raw multi-channel ECG signal in a preset segment; extracting sinusoidal parameters of powerline frequency interference, the parameters including frequency, amplitude, and phase; reconstructing a powerline frequency interference sinusoidal waveform according to the frequency, amplitude, and phase; subtracting the reconstructed powerline frequency interference sinusoidal waveform from the preset segment of the ECG signal to output a clean ECG waveform signal; characterized in that, the powerline frequency interference frequency extracted from a segment of ECG is determined by the following formula: f 0 = 1 ∑ n = 1 L a n SD n ⋅ ∑ n = 1 L a n SD n f n where L is the number of channels with the highest signal-to-noise ratio selected in the raw multi-channel ECG signal, a n is the amplitude of the powerline frequency interference signal of the nth channel estimated by a RAW-STEM method, SD n is the standard deviation of the nth channel, f n is the frequency estimate of the powerline frequency interference signal of the nth channel, and f o is the estimated frequency of the powerline frequency interference signal of all channels of the multi-channel ECG signal
A styling agent, containing, based on its weight, a) from 0.1 to 20 wt.% of setting polymer(s), b) from 0.1 to 5 wt.% of esters of the formula in which R1 represents -H or -CH 3, R2 represents a straight-chain or branched alkyl functional group having from 7 to 15 carbon atoms, n represents an integer from the group of 1, 2, 3, 4, 5, 6, 7 and 8, with the proviso that the agent contains from 0.1 to 10 wt.% copolymer(s) from N-octylacrylamide/acrylic acid/tert.-butylaminoethyl methacrylate (INCI name: octylacrylamide / acrylates / butylaminoethyl methacrylate copolymer). a) from 0.1 to 20 wt.% of setting polymer(s), b) from 0.1 to 5 wt.% of esters of the formula in which R1 represents -H or -CH 3, R2 represents a straight-chain or branched alkyl functional group having from 7 to 15 carbon atoms, n represents an integer from the group of 1, 2, 3, 4, 5, 6, 7 and 8, with the proviso that the agent contains from 0.1 to 10 wt.% copolymer(s) from N-octylacrylamide/acrylic acid/tert.-butylaminoethyl methacrylate (INCI name: octylacrylamide / acrylates / butylaminoethyl methacrylate copolymer). R1 represents -H or -CH 3, R2 represents a straight-chain or branched alkyl functional group having from 7 to 15 carbon atoms, n represents an integer from the group of 1, 2, 3, 4, 5, 6, 7 and 8,
A plate laminate type heat exchanger obtained by laminating and fixing by brazing plural plates, wherein: at least one of each of adjacent plates is a cladding material cladded with a brazing material on a surface on the other side; and in each of laminated plates, a round hole penetrating in a laminate direction is formed, and a fixing pin is inserted so as to communicate the round hole in each of plates, characterized in that: the fixing pin is expanded only in an outer diameter at one end part in a longitudinal direction thereof, and an outer periphery edge part expanded in diameter is fitted to an inner wall of the round hole. at least one of each of adjacent plates is a cladding material cladded with a brazing material on a surface on the other side; and in each of laminated plates, a round hole penetrating in a laminate direction is formed, and a fixing pin is inserted so as to communicate the round hole in each of plates, characterized in that: the fixing pin is expanded only in an outer diameter at one end part in a longitudinal direction thereof, and an outer periphery edge part expanded in diameter is fitted to an inner wall of the round hole.
Method of anodizing an article of aluminium or aluminium alloy for applying a porous anodic oxide coating in preparation of the subsequent application of an adhesive bonding layer and/or a primer layer, comprising the steps of - an immersion step of immersing the article to be anodized in an electrolyte in a tank, wherein the electrolyte consists of an aqueous solution of sulphuric acid and phosphoric acid, wherein the aluminium concentration in the electrolyte is optionally maintained at a value of 4.8 g/l or less, and arranging the article as an anode with respect to one or more counter electrodes that are arranged as cathodes in the electrolyte: - an anodizing step of applying a positive anode voltage Va to the article switched as anode, wherein the concentration of sulphuric acid in the electrolyte is in the range of 5-50 g/l, the concentration of phosphoric acid in the electrolyte is in the range of 2-50 g/l, the temperature of the electrolyte is in the range of 33-60 °C during the anodizing step, and wherein the anodizing time is in the range of 15-35 minutes and the positive anode voltage is varied to achieve a current density of 0.8 ± 0.4 A/dm 2. - an immersion step of immersing the article to be anodized in an electrolyte in a tank, wherein the electrolyte consists of an aqueous solution of sulphuric acid and phosphoric acid, wherein the aluminium concentration in the electrolyte is optionally maintained at a value of 4.8 g/l or less, and arranging the article as an anode with respect to one or more counter electrodes that are arranged as cathodes in the electrolyte: - an anodizing step of applying a positive anode voltage Va to the article switched as anode,
A scoring or cutting balloon catheter for angioplasty or coronary angioplasty of a vessel or tissue comprising: a shaft having a proximal portion and a distal portion; an inflatable balloon carried at the distal portion of the shaft; a coating comprising: at least one drug or drug preparation, the drug being (i) a taxane, (ii) an immunosuppressant belonging to the class of substances binding to the mammalian target of rapamycin, (iii) thalidomide, (iv) a statin, (v) a corticoid or a lipophilic derivative of a corticoid; and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein the at least one lipophilic antioxidant is selected from butylated hydroxytoluene, butylated hydroxyanisole, nordihydroguaiaretic acid, and propyl gallate, wherein a combination of limus drugs with butylated hydroxytoluene as the lipophilic antioxidant is excluded, and wherein the coating is carried on more than 50% of a surface of the inflatable balloon. a shaft having a proximal portion and a distal portion; an inflatable balloon carried at the distal portion of the shaft; a coating comprising: at least one drug or drug preparation, the drug being (i) a taxane, (ii) an immunosuppressant belonging to the class of substances binding to the mammalian target of rapamycin, (iii) thalidomide, (iv) a statin, (v) a corticoid or a lipophilic derivative of a corticoid; and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein the at least one lipophilic antioxidant is selected from butylated hydroxytoluene, butylated hydroxyanisole, nordihydroguaiaretic acid, and propyl gallate, wherein a combination of limus drugs with butylated hydroxytoluene as the lipophilic antioxidant is excluded, and wherein the coating is carried on more than 50% of a surface of the inflatable balloon. at least one drug or drug preparation, the drug being (i) a taxane, (ii) an immunosuppressant belonging to the class of substances binding to the mammalian target of rapamycin, (iii) thalidomide, (iv) a statin, (v) a corticoid or a lipophilic derivative of a corticoid; and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein the at least one lipophilic antioxidant is selected from butylated hydroxytoluene, butylated hydroxyanisole, nordihydroguaiaretic acid, and propyl gallate, wherein a combination of limus drugs with butylated hydroxytoluene as the lipophilic antioxidant is excluded, and wherein the coating is carried on more than 50% of a surface of the inflatable balloon.
Radio resource manager configured to assign communication resources of at least one base station to user entities depending on a media presentation description relating to a media content transferred within a data traffic from a server to a client with one of the server and the client operating at one of the user entities, wherein the radio resource manager is further configured to inspect the media presentation description so as to identify within the media presentation description a version of the media content, which has a lower minimum bandwidth associated therewith than a version of the media content, currently downloaded by the client via the at least one base station, and perform the assignment of the communication resources to the user entities dependent on as to whether such a version having a lower minimum bandwidth associated therewith is present or absent, such that the communication resources assigned to the one user entity are more likely - related to equal probability among possible states of remaining parameters depending on which the resource manager assigns the communications resources - to be lower in case of the version having a lower minimum bandwidth associated therewith being present, than compared to the case of the version having a lower minimum bandwidth associated therewith being absent.
A stabilized oxygen transport matrix comprising a reversible oxygen binding protein which is immobilized throughout the stabilized oxygen transport matrix, whereby the matrix is capable of transporting oxygen from a region of relatively high oxygen surrounding one surface of the stabilized matrix to a region of lower or no oxygen surrounding a second surface; and whereby both surfaces are permeable to oxygen; and wherein the matrix further comprises a membrane which encapsulates all or a portion of the stabilized oxygen transport matrix.
A side air bag device which is configured to be provided between a vehicle body and a back seat, comprising: an expandable air bag; an inflator configured to supply gas into the air bag;and a base member (20, 320, 420) including a base storage (24, 124, 224, 324, 424) configured to store the air bag in a folded state and the inflator, the base member (20, 320, 420) is configured to be attached between a vehicle body door and the back seat, characterized in that the side air bag device further comprising a retainer member (30, 130, 230, 330, 430) configured to hold the base storage (24, 124, 224, 324, 424) from a vehicle back side, wherein the retainer member (30, 130, 230, 330, 430) has an inner wall portion disposed on the vehicle inner side, and the inner wall portion includes a hole into which an assembly shaft of the inflator is inserted. an expandable air bag; an inflator configured to supply gas into the air bag;and a base member (20, 320, 420) including a base storage (24, 124, 224, 324, 424) configured to store the air bag in a folded state and the inflator, the base member (20, 320, 420) is configured to be attached between a vehicle body door and the back seat, characterized in that the side air bag device further comprising a retainer member (30, 130, 230, 330, 430) configured to hold the base storage (24, 124, 224, 324, 424) from a vehicle back side, wherein the retainer member (30, 130, 230, 330, 430) has an inner wall portion disposed on the vehicle inner side, and the inner wall portion includes a hole into which an assembly shaft of the inflator is inserted.